Abstract

Epithelioid hemangioendotheliomas (EHEs) are vascular tumors of intermediate malignancy that can undergo high-grade malignant transformations. EHEs have been characterized by tumor-specific WW domain-containing transcription regulator 1(WWTR1)-calmodulin-binding transcription activator 1 (CAMTA1) translocations, and recently, a novel Yes-associated protein 1 (YAP1)-transcription factor E3 (TFE3) gene fusion was identified in EHEs. In this study, we examined the expression levels of TFE3 and CAMTA1 via immunohistochemical staining and identified chromosomal alterations using fluorescence in situ hybridization (FISH) assays and RT-PCR tests. Although all of the EHEs were CAMTA1-positive in immunohistochemical staining, only five out of 18 EHEs (27.78%) positively expressed nuclear TFE3. The five TFE3-positive EHEs exhibited TFE3 gene break-apart in FISH assays. YAP1-TFE3 gene fusions were confirmed by RT-PCR. Interestingly, we observed CAMTA1 gene break-apart in all of the five TFE3-positive EHEs via FISH assays, and four out of the five TFE3-positive EHEs exhibited WWTR1-CAMTA1 gene fusions via RT-PCR. These results indicate that these two chromosomal alterations are not mutually exclusive but compossible in EHEs. Finally, primary tumor sites in TFE3-positive EHEs consistently contained single masses (P = 0.0359) with larger sizes (P = 0.0550) compared to TFE3-negative EHEs. Similar to previous reports, we observed well-formed vessels more frequently in TFE3-positive EHEs than in TFE3-negative EHEs (P = 0.0441). In addition, TFE3-positive EHEs tended to more frequently demonstrate high-grade nuclear atypia (P = 0.0654) and hypercellularity (P=0.0987) than TFE3-negative EHEs. Thus, we have now established two clinically distinct subgroups of EHEs: TFE3-positive and TFE3-negative EHEs.

Highlights

  • Epithelioid hemangioendotheliomas (EHEs) are malignant angiocentric vascular neoplasms composed of chains and cords of epithelioid endothelial cells distributed in a myxohyaline stroma [1]

  • EHEs have been characterized by tumor-specific WW domain-containing transcription regulator 1(WWTR1)-calmodulin-binding transcription activator 1 (CAMTA1) translocations, and recently, a novel Yes-associated protein 1 (YAP1)-transcription factor E3 (TFE3) gene fusion was identified in EHEs

  • Researchers identified a novel fusion between the Yesassociated protein 1 (YAP1) gene and the transcription factor E3 (TFE3) gene, which defined a distinct subset of EHEs characterized by somewhat different histological morphologies, including focally well-formed vascular channels and variably solid architectures, clinically occurred in young adults [6, 7]

Read more

Summary

Introduction

Epithelioid hemangioendotheliomas (EHEs) are malignant angiocentric vascular neoplasms composed of chains and cords of epithelioid endothelial cells distributed in a myxohyaline stroma [1]. Researchers identified a novel fusion between the Yesassociated protein 1 (YAP1) gene and the transcription factor E3 (TFE3) gene, which defined a distinct subset of EHEs characterized by somewhat different histological morphologies, including focally well-formed vascular channels and variably solid architectures, clinically occurred in young adults [6, 7]. It remains unclear if these two distinct chromosomal alterations, the WWTR1-CAMTA1 fusion and the YAP1-TFE3 fusion are mutually www.impactjournals.com/oncotarget

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call